| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |